HCA HealthcareHCA.NValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 16, 2026, HCA Healthcare (HCA.N) trades at a P/E of 14.50x, P/B of Negative, P/S of 1.27x, and a dividend yield of 0.50%.
Longitudinal percentile comparison: P/E sits at the 70th percentile over the trailing 10Y window (vs. 43rd percentile over 3Y); P/B historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/S sits at the 79th percentile over the trailing 10Y window (vs. 59th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 27th percentile within its industry and the 37th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 10.63%, ranking at the 81st percentile over the trailing 20Y window.
Relative to industry peers, its P/E shows a deeper discount than it does against the broader market. Breaking down the total shareholder yield: 0.50% comes from cash dividends, with an implied ~10.13% from buybacks — a fairly balanced mix of both channels. HCA Healthcare operates in the Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NYSE: HCA · HCA
Want the full picture on whether HCA Healthcare (HCA.N) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 14.50 | ||||||
| P/B (MRQ) | -14.96 | Negative | Negative | Negative | Negative | Negative | Negative |
| P/S (TTM) | 1.27 | ||||||
| Dividend Yield | 0.50% | ||||||
| Buyback + Div Yield | 10.63% |